Verge Genomics to Present at Mass General Brigham & Bank of America World Medical Innovation Forum
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Verge Genomics, a clinical-stage, biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery, announced today that Robert H. Scannevin, Ph.D., Chief Scientific Officer, will join other experts in a panel discussion...
Source: pharmiweb.com